285 related articles for article (PubMed ID: 17267338)
1. Comparative evaluation of the in vitro antimycobacterial activities of six aminoglycoside antibiotics using an agar dilution method.
Udou T
J Chemother; 2006 Dec; 18(6):610-6. PubMed ID: 17267338
[TBL] [Abstract][Full Text] [Related]
2. In Vitro activities of isepamicin, other aminoglycosides, and capreomycin against clinical isolates of rapidly growing mycobacteria in Taiwan.
Shen GH; Wu BD; Wu KM; Chen JH
Antimicrob Agents Chemother; 2007 May; 51(5):1849-51. PubMed ID: 17353252
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC
J Infect Dis; 1976 Nov; 134 SUPPL():S394-90. PubMed ID: 825591
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of a new isothiazoloquinolone, ACH-702, against Mycobacterium tuberculosis and other mycobacteria.
Molina-Torres CA; Ocampo-Candiani J; Rendón A; Pucci MJ; Vera-Cabrera L
Antimicrob Agents Chemother; 2010 May; 54(5):2188-90. PubMed ID: 20231398
[TBL] [Abstract][Full Text] [Related]
5. In-vitro activities of aminoglycoside-aminocyclitols against mycobacteria.
Ho YI; Chan CY; Cheng AF
J Antimicrob Chemother; 1997 Jul; 40(1):27-32. PubMed ID: 9249201
[TBL] [Abstract][Full Text] [Related]
6. [Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing].
Gui J; Wang F; Hong CY; Li JL; Liang J
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):567-71. PubMed ID: 24252731
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial agents--Part II. The aminoglycosides: streptomycin, kanamycin, gentamicin, tobramycin, amikacin, neomycin.
Brewer NS
Mayo Clin Proc; 1977 Nov; 52(11):675-9. PubMed ID: 336988
[TBL] [Abstract][Full Text] [Related]
8. [Comparative activity of habekacin and 4 other aminoglycosides against gram-negative bacilli. Evolution of resistance].
Reynaud AE; Coude du Foresto B; Derriennic M; Courtieu AL
Pathol Biol (Paris); 1988 May; 36(5):435-8. PubMed ID: 3136424
[TBL] [Abstract][Full Text] [Related]
9. Comparison of bactericidal activities of streptomycin, amikacin, kanamycin, and capreomycin against Mycobacterium avium and M. tuberculosis.
Heifets L; Lindholm-Levy P
Antimicrob Agents Chemother; 1989 Aug; 33(8):1298-301. PubMed ID: 2478073
[TBL] [Abstract][Full Text] [Related]
10. In vitro anti-mycobacterial activity of some new amino-glycoside antibiotics.
Gangadharam PR; Candler ER
Tubercle; 1977 Mar; 58(1):35-8. PubMed ID: 405778
[TBL] [Abstract][Full Text] [Related]
11. In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.
Heidarieh P; Mirsaeidi M; Hashemzadeh M; Feizabadi MM; Bostanabad SZ; Nobar MG; Hashemi Shahraki A
Microb Drug Resist; 2016 Mar; 22(2):172-8. PubMed ID: 26468990
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of recently isolated bacteria to amikacin in vitro: comparisons with four other aminoglycoside antibiotics.
Finland M; Garner C; Wilcox C; Sabath LD
J Infect Dis; 1976 Nov; 134 SUPPL():S297-307. PubMed ID: 825588
[TBL] [Abstract][Full Text] [Related]
13. Wild-type MIC distributions for aminoglycoside and cyclic polypeptide antibiotics used for treatment of Mycobacterium tuberculosis infections.
Juréen P; Angeby K; Sturegård E; Chryssanthou E; Giske CG; Werngren J; Nordvall M; Johansson A; Kahlmeter G; Hoffner S; Schön T
J Clin Microbiol; 2010 May; 48(5):1853-8. PubMed ID: 20237102
[TBL] [Abstract][Full Text] [Related]
14. Mutational resistance as the mechanism of acquired drug resistance to aminoglycosides and antibacterial agents in Mycobacterium fortuitum and Mycobacterium chelonei. Evidence is based on plasmid analysis, mutational frequencies, and aminoglycoside-modifying enzyme assays.
Wallace RJ; Hull SI; Bobey DG; Price KE; Swenson JM; Steele LC; Christensen L
Am Rev Respir Dis; 1985 Aug; 132(2):409-16. PubMed ID: 4026065
[TBL] [Abstract][Full Text] [Related]
15. Amikacin, an aminoglycoside with marked activity against antibiotic-resistant clinical isolates.
Price KE; DeFuria MD; Pursiano TA
J Infect Dis; 1976 Nov; 134 SUPPL():S249-61. PubMed ID: 62814
[TBL] [Abstract][Full Text] [Related]
16. Activity of amikacin against Mycobacteria in vitro and in murine tuberculosis.
Sanders WE; Hartwig C; Schneider N; Cacciatore R; Valdez H
Tubercle; 1982 Sep; 63(3):201-8. PubMed ID: 6817487
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth.
Wallace RJ; Nash DR; Steele LC; Steingrube V
J Clin Microbiol; 1986 Dec; 24(6):976-81. PubMed ID: 3097069
[TBL] [Abstract][Full Text] [Related]
18. In vitro activities of DC-159a, a novel fluoroquinolone, against Mycobacterium species.
Disratthakit A; Doi N
Antimicrob Agents Chemother; 2010 Jun; 54(6):2684-6. PubMed ID: 20368403
[TBL] [Abstract][Full Text] [Related]
19. [Identification and drug susceptibility testing of
Li WB; Ji LY; Xu DL; Liu HC; Zhao XQ; Wu YM; Wan KL
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 May; 39(5):669-672. PubMed ID: 29860815
[No Abstract] [Full Text] [Related]
20. Antimicrobial activity of arbekacin, a new aminoglycoside antibiotic, against methicillin-resistant Staphylococcus aureus.
Inoue M; Nonoyama M; Okamoto R; Ida T
Drugs Exp Clin Res; 1994; 20(6):233-9. PubMed ID: 7758395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
